Anesth Analg 1999;88:160-165
© 1999 International Anesthesia Research Society
REGIONAL ANESTHESIA AND PAIN MANAGEMENT
The Effects on Resting Ventilation of Intravenous Infusions of Morphine or Sameridine, a Novel Molecule with Both Local Anesthetic and Opioid Properties
Åsa Österlund, MD,
Eva Arlander, MScPharm,
Lars I. Eriksson, MD, PhD, and
Sten G. E. Lindahl, MD, PhD, FRCA
The Department of Anaesthesiology and Intensive Care, Karolinska Hospital and Institute, Stockholm, Sweden
Address correspondence and reprint requests to Åsa Österlund, MD, Department of Anaesthesiology and Intensive Care, Karolinska Hospital and Institute, SE-171 76 Stockholm, Sweden.
Sameridine has both local anesthetic and partial µ-opioid receptor agonistic properties. The aim of this single-blinded, randomized, three-way cross-over study of 12 subjects was to investigate the effects on resting ventilation of two doses of sameridine: 0.15 mg/kg (S-Small) and 0.73 mg/kg (S-Large) compared with 0.10 mg/kg morphine. Each drug was infused IV over 20 min. Ventilation was measured by pneumotachography and in-line capnography, and sedation was rated by the subjects using a visual analog scale (VAS). Plasma was collected and analyzed for sameridine and morphine. At the end of drug infusion, minute ventilation ( E) and tidal volume (VT) were reduced in the S-Large group, and E was reduced in the morphine group. End-tidal CO2 increased in both groups (P < 0.05), but respiratory rates remained unchanged. In the S-Small group, no ventilatory changes were recorded. In the S-Large group, the median sedation score was 6.8 cm with corresponding values in the morphine and S-Small groups of 3.3 and 2.5 cm, respectively. There was a relationship between the plasma concentration of sameridine and the depression of ventilation. We conclude that sameridine influences resting ventilation and that this effect is directly related to plasma concentrations of sameridine. From a ventilatory aspect, a clinical dose of sameridine with both local anesthetic and opioid properties seems safe.
Implications: Sameridine, a molecule with both local anesthetic and analgesic properties, impaired resting ventilation after a large IV dose (0.73 mg/kg), more so than 0.10 mg/kg IV morphine. A clinical dose of sameridine (0.15 mg/kg) did not have any effects on ventilation.
This article has been cited by other articles:

|
 |

|
 |
 
E. Kozer, Z. Levichek, N. Hoshino, B. Kapur, J. Leombruno, N. Taguchi, F. Garcia-Bournissen, G. Koren, and S. Ito
The Effect of Amitriptyline, Gabapentin, and Carbamazepine on Morphine-Induced Hypercarbia in Rabbits
Anesth. Analg.,
October 1, 2008;
107(4):
1216 - 1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego
The Endomorphin System and Its Evolving Neurophysiological Role
Pharmacol. Rev.,
March 1, 2007;
59(1):
88 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Modalen, L. Westman, E. Arlander, L. I. Eriksson, and S. G. E. Lindahl
Hypercarbic and Hypoxic Ventilatory Responses After Intrathecal Administration of Bupivacaine and Sameridine
Anesth. Analg.,
February 1, 2003;
96(2):
570 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Osterlund Modalen, E. Arlander, L. I. Eriksson, and S. G. E. Lindahl
The Effects on Hypercarbic Ventilatory Response of Sameridine Compared to Morphine and Placebo
Anesth. Analg.,
February 1, 2001;
92(2):
529 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|